Increased frequency of travel in the presence of cross-immunity may act to decrease the chance of a global pandemic

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 374, Issue 1775, 2019, Pages

  Thompson, R N ^a,b   Thompson, C P ^a   Pelerman, O ^c   Gupta, S ^a   Obolski, U ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHRIST CHURCH   (United Kingdom)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antigenic variation; Cross immunity; Major epidemic; Mathematical modelling; Pathogen diversity

Indexed keywords

ANTIGEN; EPIDEMIC; INFECTIOUS DISEASE; INFLUENZA; NUMERICAL MODEL; PATHOGEN; PROBABILITY; SUBPOPULATION; VIRULENCE;

ANIMALIA;

CROSS PROTECTION; EPIDEMIC; GLOBAL HEALTH; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS; PANDEMIC; PATHOGENICITY; PHYSIOLOGY; PROBABILITY; THEORETICAL MODEL; TRAVEL; VIRULENCE;

CROSS PROTECTION; DISEASE OUTBREAKS; GLOBAL HEALTH; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MODELS, THEORETICAL; PANDEMICS; PROBABILITY; TRAVEL; VIRULENCE;

EID: 85065433539     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2018.0274     Document Type: Article

References (61)

1. Taylor LH, Latham SM, Mark EJ. 2001 Risk factors for human disease emergence. Phil. Trans. R. Soc. Lond. B 356, 983-989. (doi:10.1098/rstb.2001. 0888)
2. Dye C. 2014 After 2015: infectious diseases in a new era of health and development. Phil. Trans. R. Soc. B 369, 20130426. (doi:10.1098/rstb.2013.0426)
3. Reperant LA, Osterhaus AD. 2017 AIDS, Avian flu, SARS, MERS, Ebola, Zika. . . what next? Vaccine 35, 4470 - 4474. (doi:10.1016/j.vaccine.2017. 04.082)
4. Coltart CE, Lindsey B, Ghinai I, Johnson AM, Heymann DL. 2017 The Ebola outbreak, 2013-2016: old lessons for new epidemics. Phil. Trans. R. Soc. B 372, 20160297. (doi:10.1098/rstb. 2016.0297)
5. Girard MP, Tam JS, Assossou OM, Kieny MP. 2010 The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 28, 4895-4902. (doi:10.1016/j. vaccine.2010.05.031)
6. SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K. 2010 The public's response to the 2009 H1N1 influenza pandemic. New Engl. J. Med. 362, e65. (doi:10.1056/NEJMp1005102)
7. Johnson NP, Mueller J. 2002 Updating the accounts: global mortality of the 1918-1920 'Spanish' influenza pandemic. Bull. Hist. Med. 76, 105-115. (doi:10.1353/bhm.2002.0022)
8. Kilbourne ED. 2006 Influenza pandemics of the 20th century. Emerg. Infect. Dis. 12, 9-14. (doi:10.3201/ eid1201.051254)
9. Saunders-Hastings PR, Krewski D. 2016 Reviewing the history of pandemic influenza: understanding patterns of emergence and transmission. Pathogens 5, 66. (doi:10.3390/pathogens5040066)
10. Getz WM, Lloyd-Smith JO, Cross PC, Bar-David S, Johnson PL, Porco TC, Sánchez MS. 2006 Modeling the invasion and spread of contagious diseases in heterogeneous populations. In Disease evolution: models, concepts, and data analyses (eds Z Feng, U Dieckmann, SA Levin), pp. 113-144. Piscataway, NJ: DIMACS.
11. Engering A, Hogerwerf L, Slingenbergh J. 2013 Pathogen-host-environment interplay and disease emergence. Emerg. Microbes Infect. 2, e5. (doi:10. 1038/emi.2013.5)
12. Gupta S, Anderson RM, May RM. 1989 Networks of sexual contacts: implications for the pattern of spread of HIV. AIDS 3, 807-817. (doi:10.1097/ 00002030-198912000-00005)
13. Woolhouse ME, Shaw DJ, Matthews L, Liu WC, Mellor DJ, Thomas MR. 2005 Epidemiological implications of the contact network structure for cattle farms and the 20-80 rule. Biol. Lett. 1, 350-352. (doi:10.1098/rsbl.2005.0331)
14. Keeling MJ. 2005 The implications of network structure for epidemic dynamics. Theor. Pop. Biol. 67, 1-8. (doi:10.1016/j.tpb.2004.08.002)
15. Woolhouse ME. 2011 How to make predictions about future infectious disease risks. Phil. Trans. R. Soc. B 366, 2045-2054. (doi:10.1098/rstb.2010.0387)
16. Mangili A, Gendreau MA. 2005 Transmission of infectious diseases during commercial air travel. Lancet 365, 989-996. (doi:10.1016/S0140-6736(05)71089-8)
17. Vossen MT, Westerhout EM, Söderberg-Nauclér C, Wiertz EJ. 2002 Viral immune evasion: a masterpiece of evolution. Immunogenetics 54, 527-542. (doi:10.1007/s00251-002-0493-1)
18. Finlay BB, McFadden G. 2006 Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124, 767-782. (doi:10.1016/j. cell.2006.01.034)
19. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004 Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371-376. (doi:10. 1126/science.1097211)
20. Gandon S, Mackinnon MJ, Nee S, Read AF. 2001 Imperfect vaccines and the evolution of pathogen virulence. Nature 414, 751-756. (doi:10.1038/ 414751a)
21. Obolski U, Lourenço J, Thompson CP, Thompson RN, Gori A, Gupta S. 2018 Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae. Proc. Natl Acad. Sci. USA 115, 3102-3107. (doi:10.1073/pnas.1718712115)
22. Gog JR, Grenfell BT. 2002 Dynamics and selection of many-strain pathogens. Proc. Natl Acad. Sci. USA 99, 17 209 - 17 214. (doi:10.1073/pnas.252512799)
23. Grenfell BT, Pybus OG, Gog JR, Wood JL, Daly JM, Mumford JA, Holmes EC. 2004 Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303, 327-332. (doi:10.1126/ science.1090727)
24. Reich NG et al. 2013 Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. J. R. Soc. Interface 10, 20130414. (doi:10.1098/rsif.2013.0414)
25. Thompson CP et al. 2018 A naturally protective epitope of limited variability as an influenza vaccine target. Nat. Commun. 9, 3859. (doi:10.1038/s41467-018-06228-8)
26. Thompson CP, Obolski U. 2018 Influenza vaccination and the 'diversity paradox'. Hum. Vaccin. Immunother. 14, 3005-3009. (doi:10.1080/ 21645515.2018.1504596)
27. Koelle K, Pascual M, Yunus M. 2006 Serotype cycles in cholera dynamics. Proc. R. Soc. Lond. B 273, 2879-2886. (doi:10.1098/rspb.2006.3668)
28. White LJ, Waris M, Cane PA, Nokes DJ, Medley GF. 2005 The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection. Epidem. Infect. 133, 279-289. (doi:10. 1017/S0950268804003450)
29. Bhattacharyya S, Gesteland PH, Korgenski K, Bjørnstad ON, Adler FR. 2015 Cross-immunity between strains explains the dynamical pattern of paramyxoviruses. Proc. Natl Acad. Sci. USA 112, 13 396 - 13 400. (doi:10.1073/pnas.1516698112)
30. Gupta S, Maiden MC, Feavers IM, Nee S, May RM, Anderson RM. 1996 The maintenance of strain structure in populations of recombining infectious agents. Nat. Med. 2, 437 - 442. (doi:10.1038/nm0496-437)
31. Gupta S, Ferguson N, Anderson R. 1998 Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 280, 912-915. (doi:10.1126/science.280.5365.912)
32. Hancock K et al. 2009 Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. New Engl. J. Med. 361, 1945-1952. (doi:10. 1056/NEJMoa0906453)
33. Zimmer SM et al. 2010 Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE 5, e11601. (doi:10.1371/journal.pone.0011601)
34. Ikonen N, Strengell M, Kinnunen L, Österlund P, Pirhonen J, Broman M, Davidkin I, Ziegler T, Julkunen I. 2010 High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill. 15, 19478.
35. Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P. 2013 Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci. Transl. Med. 5, 198ra107. (doi:10.1126/ scitranslmed.3006637)
36. Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ. 2006 Delaying the international spread of pandemic influenza. PLoS Med. 3, e212. (doi:10.1371/journal. pmed.0030212)
37. Gagnon A, Miller MS, Hallman SA, Bourbeau R, Herring DA, Earn DJ, Madrenas J. 2013 Age-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortality. PLoS ONE 8, e69586. (doi:10.1371/ journal.pone.0069586)
38. Carter DM, Bloom CE, Nascimento EJ, Marques ET, Craigo JK, Cherry JL, Lipman DJ, Ross TM. 2013 Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. J. Virol. 87, 1400-1410. (doi:10.1128/JVI. 02257-12)
39. Luk J, Gross P, Thompson WW. 2001 Observations on mortality during the 1918 influenza pandemic. Clin. Inf. Dis. 33, 1375-1378. (doi:10.1086/ 322662)
40. Scholtissek C, von Hoyningen V, Rott R. 1978 Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology 89, 613-617. (doi:10.1016/0042-6822(78)90203-9)
41. Reichert T, Chowell G, McCullers JA. 2012 The age distribution of mortality due to influenza: pandemic and peri-pandemic. BMC Med. 10, 162. (doi:10. 1186/1741-7015-10-162)
42. Wilson N, Mansoor O, Lush D, Kiedrzynski T. 2005 Modeling the impact of pandemic influenza on Pacific Islands. Emerg. Infect. Dis. 11, 347-349. (doi:10.3201/eid1102.040951)
43. Ansart S, Pelat C, Boelle PY, Carrat F, Flahault A, Valleron AJ. 2009 Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respir. Viruses 3, 99-106. (doi:10.1111/j.1750-2659.2009.00080.x)
44. Central Intelligence Agency. 2018 The World Factbook. See www.webcitation.org.
45. Masumu J, Marcotty T, Geerts S, Vercruysse J, Van den Bossche P. 2009 Cross-protection between Trypanosoma congolense strains of low and high virulence. Vet. Parasitol. 163, 127-131. (doi:10. 1016/j.vetpar.2009.04.006)
46. Gal-On A, Shiboleth YM. 2006 Cross protection. In Natural resistance mechanisms of plants to viruses (eds G Loebenstein, JP Carr), pp. 261-288. Dordrecht, The Netherlands: Springer.
47. Jousimo J, Tack AJM, Ovaskainen O, Mononen T, Susi H, Tollenaere C, Laine A-L. 2014 Ecological and evolutionary effects of fragmentation on infectious disease dynamics. Science 344, 1289-1293. (doi:10.1126/science.1253621)
48. Walther GR, Post E, Convey P, Menzel A, Parmesan C, Beebee TJ, Fromentin JM, Hoegh-Guldberg O, Bairlein F. 2002 Ecological responses to recent climate change. Nature 416, 389-395. (doi:10. 1038/416389a)
49. Liebhold AM, Brockerhoff EG, Garrett LJ, Parke JL, Britton KO. 2012 Live plant imports: the major pathway for forest insect and pathogen invasions of the US. Front. Ecol. Environ. 10, 135-143. (doi:10. 1890/110198)
50. Folimonova SY, Robertson CJ, Shilts T, Folimonov AS, Hilf ME, Garnsey SM, Dawson WO. 2010 Infection with strains of Citrus tristeza virus does not exclude superinfection by other strains of the virus. J. Virol. 84, 1314-1325. (doi:10.1128/JVI.02075-09)
51. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. 1999 Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med. 5, 340-343. (doi:10.1038/6560)
52. Hellriegel B. 2001 Immunoepidemiology-bridging the gap between immunology and epidemiology. Trends Parasitol. 17, 102-106. (doi:10.1016/S1471-4922(00)01767-0)
53. Penman BS, Gupta S, Shanks GD. 2017 Rapid mortality transition of Pacific Islands in the 19th century. Epidem. Infect. 145, 1-11. (doi:10.1017/ S0950268816001989)
54. Ferguson N, Anderson R, Gupta S. 1999 The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc. Natl Acad. Sci. USA 96, 790-794. (doi:10.1073/pnas.96.2.790)
55. Thompson RN, Hart WS. 2018 Effect of confusing symptoms and infectiousness on forecasting and control of Ebola outbreaks. Clin. Inf. Dis. 67, 505-518. (doi:10.1093/cid/ciy248)
56. Ferguson NM, Donnelly CA, Anderson RM. 2001 The foot-and-mouth epidemic in Great Britain: pattern of spread and impact of interventions. Science 292, 1155-1160. (doi:10.1126/science. 1061020)
57. Thompson RN, Cobb RC, Gilligan CA, Cunniffe NJ. 2016 Management of invading pathogens should be informed by epidemiology rather than administrative boundaries. Ecol. Model. 324, 28-32. (doi:10.1016/j.ecolmodel.2015. 12.014)
58. Holmes EC, Rambaut A, Andersen KG. 2018 Pandemics: spend on surveillance, not prediction. Nature 558, 180-182. (doi:10.1038/d41586-018-05373-w)
59. World Health Organization. 2018 Annual review of diseases prioritized under the research and development blueprint. See http://www.who.int/emergencies/diseases/2018prioritization-report. pdf?ua=1.
60. Keeling MJ, Rohani P. 2007 Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press.
61. Thompson RN, Gilligan CA, Cunniffe NJ. 2016 Detecting presymptomatic infection is necessary to forecast major epidemics in the earliest stages of infectious disease outbreaks. PLoS Comp. Biol. 12, e1004836. (doi:10.1371/journal.pcbi. 1004836)